#1 Clinical Trials Search in Europe

Myrrh

Recent clinical trials have been investigating the potential uses of Myrrh, a natural resin with a long history of medicinal use. These studies focus on two distinct areas: the treatment of schistosomiasis, a parasitic infection, and the management of oral health issues such as gingivitis and dental plaque. The trials aim to compare the effectiveness and safety of Myrrh-based treatments with current standard therapies, offering potential new options for patients in these areas of healthcare.

Table of Contents

What is Myrrh?

Myrrh is a natural substance that has been used for thousands of years in traditional medicine. It is an oleo-gum resin, which means it’s a mixture of oil and gum, obtained from the stem of various species of Commiphora trees. These trees grow in northeast Africa and Arabia[1]. Myrrh is also known by other names, including Arabian Myrrh and Somali Myrrh.

Uses of Myrrh

Recent clinical trials have explored the potential of Myrrh in treating various health conditions. The two main areas of research are:

  • Treatment of schistosomiasis, a parasitic disease caused by flatworms[1]
  • Improvement of oral health, particularly in fighting gingivitis and dental plaque[2]

Myrrh for Schistosomiasis Treatment

A clinical trial has been conducted to evaluate the effectiveness of Mirazid, a drug derived from Myrrh, in treating schistosomiasis[1]. Schistosomiasis is a disease caused by parasitic worms that can affect the urinary system or intestines. The study compared Mirazid to Praziquantel, a standard treatment for this condition.

The main objectives of this study were to:

  • Compare the cure rates of Mirazid and Praziquantel for both types of Schistosoma parasites
  • Evaluate how well each drug reduces the intensity of the infection
  • Identify and compare the side effects of both treatments

The study involved 200 people aged 15-35 years who were infected with schistosomiasis. The results of this study could help determine if Mirazid is an effective alternative to current treatments for schistosomiasis[1].

Myrrh for Oral Health

Another clinical trial investigated the use of Myrrh as a mouthwash to improve oral health[2]. This study compared a 1% Myrrh mouthwash to a standard 0.2% chlorhexidine mouthwash and a placebo (salt water) solution.

The researchers were interested in several aspects of oral health:

  • Plaque reduction: Plaque is a sticky film of bacteria that forms on teeth and can lead to tooth decay and gum disease
  • Gingivitis reduction: Gingivitis is a mild form of gum disease that causes irritation, redness, and swelling of the gums
  • Anti-inflammatory effects: The study measured levels of a substance called interleukin-1β, which is involved in inflammation

The study participants used their assigned mouthwash twice daily for 14 days. The researchers then compared the effects of each mouthwash on plaque, gingivitis, and inflammation[2].

Dosage and Administration

The dosage and administration of Myrrh can vary depending on its use:

  • For schistosomiasis treatment: Mirazid (the Myrrh-based drug) was given as 600 mg oral soft gelatin capsules for 6 consecutive days[1]
  • As a mouthwash: A 1% Myrrh mouthwash solution was used. Participants rinsed with 10 ml of the mouthwash twice daily for 1 minute[2]

It’s important to note that these dosages were used in clinical trials and may not represent standard recommendations. Always consult with a healthcare professional before using Myrrh or any other herbal remedy.

Side Effects and Safety

One of the objectives of the schistosomiasis study was to identify and compare the types and severity of side effects between Mirazid (the Myrrh-based drug) and Praziquantel[1]. However, specific information about these side effects is not provided in the available data.

For the oral health study, the researchers monitored for any adverse effects throughout the trial period[2]. While detailed information about side effects is not given, it’s worth noting that the study compared Myrrh mouthwash to chlorhexidine, which is considered a gold standard in dental care.

As with any medication or herbal remedy, it’s crucial to consult with a healthcare provider before using Myrrh, especially if you have any existing health conditions or are taking other medications.

Aspect Schistosomiasis Trial Oral Health Trial
Myrrh Form Mirazid (600 mg oral capsules) 1% Myrrh mouthwash
Comparison Treatment Praziquantel (40mg/kg body weight) 0.2% Chlorhexidine mouthwash
Duration 6 consecutive days, evaluated at 12 weeks 14 days, evaluated at baseline, day 7, and day 14
Primary Outcomes Cure rates, reduction in infection intensity Change in IL-1β levels (inflammation marker)
Secondary Outcomes Side effects comparison Changes in gingivitis, plaque accumulation, gingival bleeding
Study Population 200 Schistosomiasis-infected persons, aged 15-35 Periodontally healthy adult volunteers

FAQ

  • What is Myrrh and how is it being used in clinical trials? Myrrh is an oleo-gum resin obtained from the stem of various Commiphora species. In clinical trials, it's being used in two main ways: as Mirazid, a treatment for schistosomiasis, and as a 1% mouthwash solution for oral health issues like gingivitis and dental plaque.
  • How does Mirazid compare to standard schistosomiasis treatment? A Phase III trial is comparing Mirazid (made from Myrrh) to Praziquantel, the standard treatment for schistosomiasis. The study aims to compare their cure rates, ability to lower infection intensity, and side effects in treating both types of Schistosoma infections.
  • What are the potential benefits of Myrrh mouthwash? A clinical trial is investigating whether a 1% Myrrh mouthwash can reduce dental plaque, gingivitis, and inflammation. It's being compared to 0.2% chlorhexidine mouthwash, which is currently considered the gold standard for oral rinses.
  • How long do patients use the Myrrh mouthwash in the oral health trial? In the oral health trial, participants use 10 ml of the assigned mouthwash (either Myrrh, chlorhexidine, or saline) twice daily for 14 days. The effects are evaluated by comparing baseline measurements with those taken after the two-week intervention period.
  • What outcomes are being measured in these Myrrh-based clinical trials? For the schistosomiasis trial, the main outcomes are cure rates and reduction in infection intensity. For the oral health trial, outcomes include changes in gingival inflammation (measured by IL-1β levels), gingivitis severity, plaque accumulation, and gingival bleeding.

Ongoing Clinical Trials on Myrrh

  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome

    Recruiting

    1 1 1
    Investigated drugs:
    Germany

  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Predominant Irritable Bowel Syndrome

    Recruiting

    1 1 1
    Investigated drugs:
    Germany

Glossary

  • Schistosomiasis: A parasitic disease caused by flatworms called schistosomes. It affects millions of people worldwide, particularly in tropical and subtropical areas.
  • Mirazid: An antischistosomal drug derived from Myrrh, used in the treatment of schistosomiasis.
  • Praziquantel: The current standard treatment for schistosomiasis, used as a comparison in the Mirazid trial.
  • Gingivitis: Inflammation of the gums, often caused by plaque buildup. It's an early stage of gum disease that can be reversed with proper oral care.
  • Dental Plaque: A sticky film of bacteria that constantly forms on teeth. If not removed regularly, it can lead to tooth decay and gum disease.
  • Chlorhexidine: An antiseptic and disinfectant agent commonly used in mouthwashes to reduce dental plaque and oral bacteria.
  • Interleukin-1β (IL-1β): A protein involved in the body's inflammatory response. In the oral health study, it's used as a marker to measure gum inflammation.
  • Modified Gingival Index (MGI): A scale used to assess the severity of gingivitis, ranging from 0 (normal gums) to 3 (severe inflammation).
  • Plaque Index (PI): A measure used to assess the amount of dental plaque on teeth surfaces.
  • Gingival Bleeding Index (GBI): A method to assess gum health by measuring how easily the gums bleed when gently probed.

References

  1. https://clinicaltrials.gov/study/NCT01529710
  2. https://clinicaltrials.gov/study/NCT04723732